Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Canada
/
Pharmaceuticals & Biotech
Create a narrative
BioSyent Community
TSXV:RX Community
0
Narratives
written by author
0
Comments
on narratives written by author
7
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
BioSyent
Popular
Undervalued
Overvalued
There are no community narratives available.
Your Valuation for
RX
RX
BioSyent
Your Fair Value
CA$
Current Price
CA$11.45
21.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
56m
2015
2018
2021
2024
2025
2027
2030
Revenue CA$56.0m
Earnings CA$11.4m
Advanced
Set Fair Value
